Drug Shortage Report for CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE

Last updated on 2025-04-15 History
Report ID 253444
Drug Identification Number 02408813
Brand name CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
Common or Proper name CISATRACURIUM BESYLATE INJECTION
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) CISATRACURIUM
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 10ML VIAL / FIOLE
ATC code M03AC
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2025-03-26
Estimated end date 2025-04-15
Actual end date 2025-04-14
Shortage status Resolved
Updated date 2025-04-15
Company comments Product remains available at CPDN.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-04-15 English Compare
v5 2025-04-08 French Compare
v4 2025-04-08 English Compare
v3 2025-03-27 English Compare
v2 2025-03-26 French Compare
v1 2025-03-26 English Compare

Showing 1 to 6 of 6